Analyst Ratings for Karyopharm Therapeutics (KPTI) [Neutrals]
KPTI Rating Summary
KPTI Price Target Summary
- Highest: $10.00 (H.C. Wainwright)
- Lowest: $3.00 (RBC Capital)
- Average: $5.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$5.67 (+388.5%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 77%
Rating Score: 7.1 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/9/2022 | JPMorgan » Updated 11/4/2022 |
Eric Joseph | Upgrade | Neutral (Underweight) |
5.00 (6.00) |
10.24 (1.16) |
-88.67% | Details |
| 11/19/2021 | Morgan Stanley » Updated 8/7/2023 |
Michael Ulz | Downgrade | Equalweight (Overweight) |
4.00 (5.00) |
8.29 (1.16) |
-86.01% | Details |
 |
||||||||
|
||||||||
